AMPE
- Ampio Pharmaceuticals, Inc.
()
Overview
Company Summary
Ampio Pharmaceuticals, Inc. (AMPE) is a biopharmaceutical company that focuses on the development of innovative therapies to treat prevalent medical conditions. Their primary goal is to address unmet medical needs by researching, developing, and commercializing therapeutic products.
Ampio Pharmaceuticals primarily operates in the field of regenerative medicine, with a particular emphasis on inflammation, which is associated with various diseases and complications. The company's research is centered around the understanding of the complex processes involved in inflammation and the identification of unique target areas for therapeutic intervention.
One of Ampio Pharmaceuticals' notable products is Ampion�, which is a proprietary anti-inflammatory biologic drug. Ampion� is derived from human serum albumin and has shown promise in reducing inflammation and promoting tissue repair. It is being evaluated for the treatment of multiple medical conditions, including osteoarthritis of the knee and COVID-19 related respiratory distress.
Apart from Ampion�, Ampio Pharmaceuticals has a pipeline of other potential therapeutics at various stages of development. These include candidates targeting diseases like diabetic macular edema, chronic obstructive pulmonary disease, neuroinflammation, and other inflammatory and immunological disorders.
Additionally, Ampio Pharmaceuticals actively seeks collaborations and strategic partnerships to leverage its expertise and develop innovative therapies in collaboration with other companies in the pharmaceutical and biotechnology industry.
In summary, Ampio Pharmaceuticals, Inc. specializes in the research, development, and commercialization of novel therapies, particularly in the field of regenerative medicine. Their focus on inflammation-related medical conditions and the development of drugs like Ampion� demonstrates their dedication to addressing unmet medical needs and improving patient outcomes.